Pharmaceutical & Biotech
Industry

The pharmaceutical and biotech industry continues to flourish in the changing landscape of healthcare. Whether you focus on the discovery, development, or manufacturing of drugs and medications- we can connect you with leaders in your field to define best practices.

Pharmaceutical Conferences

6TH ANNUAL REGULATORY OPERATIONS AND SUBMISSIONS CONFERENCE

Optimizing the Development of Quality Product Submission Dossiers with a Comprehensive Understanding of Regional and Global Dossier Requirements, Ensuring Dossier Navigability and Current Publishing Technologies
MAY 22-23, 2017 | PHILADELPHIA, PA

6TH ANNUAL STRENGTHENING PATIENT ADVOCACY RELATIONS CONFERENCE

Join us in advancing the role of patient advocacy through improved collaboration with advocacy organizations, strategically measuring and benchmarking advocacy initiatives to increase support while empowering the patient community. This exciting annual meeting seamlessly blends robust educational content alongside informal networking.
JULY 25-26, 2017 | BALTIMORE, MD

Latest News from our Pharmaceutical Blog

Navigating Software Updates in the Electronic Submission Process with Pfizer

In recent years, advancements in technology have enabled regulatory operations and affairs teams to develop electronic submissions, streamlining the application process.

Read More

Measuring the Impact of Patient Advocacy

Patient advocacy is a complex field that relies on stakeholder balance and representation.

Read More

Produce MES Success

When considering implementing an automated pharmaceutical manufacturing solution, planning is crucial to shorter ROI periods and long-term success. Benchmarking this success means developing business objectives and goals for MES usage and testing.

Read More

MES Implementation and Beyond

The road to MES production starts with an initial scope and lifecycle overview. One pressing concern for pharmaceutical manufacturers is the transition to automated production, and how an MES application can increase product standardization and data reliability.

Read More

How the eCTD has Changed Submission Teams

In May of this year, regulatory operations leaders will finally begin preparing therapy submissions under one standardized format. The eCTD’s compliance deadlines will force organizations to move completely beyond clerical data formation and into the world of electronic submissions.

Read More

MES Implementation and Beyond

MES 101: Implementation and Beyond The road to MES production starts with an initial scope and lifecycle overview. One pressing concern for pharmaceutical manufacturers is the transition to automated production, and how an MES application can increase product...
Read More

How One Company is Redefining Scientific Exchange

Scientific exchange is an integral part of the pre-launch phase for medical affairs. Traditionally, this information is deployed to thought leaders who can assist in providing science-driven product feedback. Now, as digital platforms become more versatile for the medical affairs community, many companies are choosing to conduct this exchange through social media.

Read More

How the FDA Data Integrity Draft Guidance is Affecting the Pharmaceutical Industry

Data integrity, as part of an automated production system, is an important factor for the success of a pharmaceutical. Inconsistencies in data compliance can deny vital information from government agencies, payers, and patients.

Read More

Building the Pre-Launch Road-Map

Evolving complexities and increased scrutiny of the pharmaceutical industry have dictated a heavy reliance on early drug launch planning. From product research, development, and reimbursement, the first 18 months of product conceptualization can not only be the most challenging, but also the most rewarding.

Read More

Redefining the Pre-Launch MSL

Recent changes to healthcare have dictated equal and necessary changes to the product launch process. As the healthcare industry shifts towards patient-centered care, new standards have been placed on the way pharmaceutical companies should be presenting their research and products

Read More

CONTACT US
Q1 Productions
500 N. Dearborn Suite 500 | Chicago, IL 60654
Chicago, IL 60654
T: 312.822.8100
F: 312.873.3969
[email protected]

 

 

Share This